医学
红细胞压积
随机对照试验
贫血
体质指数
螺母
内科学
化疗
胃肠病学
球蛋白
大豆蛋白
免疫学
病理
结构工程
工程类
作者
Narges Ramezani,Alireza Moafi,Azadeh Nadjarzadeh,Saeed Yousefian,Nahid Reisi,Amin Salehi‐Abargouei
标识
DOI:10.1080/01635581.2018.1495240
摘要
No previous studies were found to examine the effect of soy as a whole food on patients with leukemia. The present randomized controlled clinical trial studied the effect of soy nut on children with B-cell acute lymphoblastic leukemia (ALL) who were in the maintenance phase of chemotherapy. The eligible patients were randomized to receive 30 g/day soy or cowpea nut powder for 12 weeks. Dietary intake, physical activity, anthropometric measurements, complete blood count, serum albumin, serum highly sensitive C-reactive protein (hs-CRP), and Tumor necrosis factor alpha (TNF-α) as well as chemotherapy side effects were assessed at the start and the end of the study. In total 29 and 27 children completed the study (aged 6.34 ± 2.44 and 5.85 ± 2.35 years) in soy and cowpea nut groups, respectively. The total energy and protein intake, and physical activity as well as body weight, body mass index, number of red blood cells, hemoglobin and hematocrit levels, and fatigue were significantly improved in the soy nut group compared to patients who consumed cowpea nut (P < 0.05). Soy nut intake might improve the nutritional status, anemia, and fatigue in children with ALL. Studies targeting blood cell fractions and disease recurrence are highly recommended.
科研通智能强力驱动
Strongly Powered by AbleSci AI